[go: up one dir, main page]

CN115487421A - Cardiac pacemaker system, cardiac pacing control method and electronic equipment - Google Patents

Cardiac pacemaker system, cardiac pacing control method and electronic equipment Download PDF

Info

Publication number
CN115487421A
CN115487421A CN202211123534.4A CN202211123534A CN115487421A CN 115487421 A CN115487421 A CN 115487421A CN 202211123534 A CN202211123534 A CN 202211123534A CN 115487421 A CN115487421 A CN 115487421A
Authority
CN
China
Prior art keywords
authentication
pacemaker
processor
external controller
controller
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211123534.4A
Other languages
Chinese (zh)
Inventor
侯晓彤
贾在申
杜中涛
王粮山
李呈龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Anzhen Hospital
Original Assignee
Beijing Anzhen Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Anzhen Hospital filed Critical Beijing Anzhen Hospital
Priority to CN202211123534.4A priority Critical patent/CN115487421A/en
Publication of CN115487421A publication Critical patent/CN115487421A/en
Priority to PCT/CN2023/077208 priority patent/WO2024055511A1/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/36507Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by gradient or slope of the heart potential
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37217Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37235Aspects of the external programmer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37252Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • A61N1/37512Pacemakers
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F21/00Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
    • G06F21/30Authentication, i.e. establishing the identity or authorisation of security principals
    • G06F21/44Program or device authentication
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F21/00Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
    • G06F21/30Authentication, i.e. establishing the identity or authorisation of security principals
    • G06F21/45Structures or tools for the administration of authentication
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Computer Security & Cryptography (AREA)
  • Cardiology (AREA)
  • Theoretical Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Software Systems (AREA)
  • Computer Hardware Design (AREA)
  • Business, Economics & Management (AREA)
  • Physiology (AREA)
  • Primary Health Care (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • General Business, Economics & Management (AREA)
  • Acoustics & Sound (AREA)
  • Electrotherapy Devices (AREA)

Abstract

The invention discloses a cardiac pacemaker system, a method for controlling cardiac pacing and an electronic device, wherein the cardiac pacemaker system comprises an external controller and an internal pacemaker, wherein a first authentication unit is arranged in the internal pacemaker, a second authentication unit is arranged in the external controller, and the first authentication unit is in communication connection with the second authentication unit; the internal pacemaker is used for acquiring the electrocardio information of the heart; the external controller is in communication connection with the internal pacemaker, receives the electrocardio information sent by the internal pacemaker and sends the received control instruction to the internal pacemaker. In addition, the invention also provides a method for controlling cardiac pacing. The technical scheme provided by the invention has the capabilities of bidirectional authentication and real-time electrocardio monitoring, and simultaneously has the functions of cloud connection and remote monitoring and diagnosis and treatment.

Description

一种心脏起搏器系统、控制心脏起搏的方法及电子设备A cardiac pacemaker system, a method for controlling cardiac pacing, and electronic equipment

技术领域technical field

本发明涉及医疗电子器械技术领域,尤其涉及一种心脏起搏器系统、控制心脏起搏的方法及电子设备。The invention relates to the technical field of medical electronic equipment, in particular to a cardiac pacemaker system, a method for controlling cardiac pacing and electronic equipment.

背景技术Background technique

心脏起搏器分为临时心脏起搏器和永久心脏起搏器。对于永久型心脏起搏器,其需要依赖内部的电池供电才能够工作,根据内部电池的容量,永久型心脏起搏器一般可工作5~10年,电池能量耗竭后需二次手术更换,存在较大感染风险。对于临时心脏起搏器,在使用后,往往需要拆除心肌起搏导线,在拆除心肌起搏导线的过程中可能会导致心外膜撕裂甚至心肌穿孔。对于微型心脏起搏器,可通过动脉血管微创植入,但仅为单腔起搏器,只能治疗缓慢性心率失常,且容易引起起搏器综合症,加重心衰;Pacemakers are divided into temporary and permanent pacemakers. For the permanent cardiac pacemaker, it needs to rely on the internal battery power supply to be able to work. According to the capacity of the internal battery, the permanent cardiac pacemaker can generally work for 5 to 10 years. After the battery energy is exhausted, it needs to be replaced by a second operation. Greater risk of infection. For a temporary cardiac pacemaker, after use, it is often necessary to remove the myocardial pacing lead, which may cause epicardial tear or even myocardial perforation during the removal of the myocardial pacing lead. Miniature cardiac pacemakers can be minimally invasively implanted through arterial vessels, but only single-chamber pacemakers can only treat slow arrhythmias, and are likely to cause pacemaker syndrome and aggravate heart failure;

另外,心脏人工心脏起搏器工作时脉冲间隔时间、脉冲频率以及脉冲强度等工作参数,必须在安装之前设定好,但是随着病人年龄、病情等的变换需要更改参数设置,也只能通过手术的方式取出人工心脏起搏器重新进行设置,这不仅会给病人带来二次身体伤害,且安全性不高。In addition, the pulse interval time, pulse frequency and pulse intensity and other working parameters of the cardiac artificial cardiac pacemaker must be set before installation. The way of operation is to take out the artificial cardiac pacemaker and reset it, which will not only bring secondary physical harm to the patient, but also is not safe.

发明内容Contents of the invention

本发明提供了一种心脏起搏器系统、控制心脏起搏的方法及电子设备,以解决现有技术中上述部分或全部技术问题。The present invention provides a cardiac pacemaker system, a method for controlling cardiac pacing and electronic equipment to solve some or all of the above-mentioned technical problems in the prior art.

为实现上述目标,本发明提供了以下技术方案:In order to achieve the above object, the present invention provides the following technical solutions:

第一方面,本发明提供了一种心脏起搏器系统,包括体外控制器及体内起搏器,其中,所述体内起搏器内设置有第一鉴权单元,所述体外控制器内设置有第二鉴权单元,所述第一鉴权单元和所述第二鉴权单元通信连接;In a first aspect, the present invention provides a cardiac pacemaker system, including an external controller and an internal pacemaker, wherein a first authentication unit is arranged in the internal pacemaker, and a first authentication unit is arranged in the external controller. There is a second authentication unit, and the first authentication unit is communicatively connected to the second authentication unit;

所述体内起搏器,用于获取心脏的心电信息;The internal pacemaker is used to obtain the electrocardiographic information of the heart;

所述体外控制器,与所述体内起搏器通信连接,接收所述体内起搏器发送的所述心电信息,并将接收的控制指令发送给所述体内起搏器。The external controller is communicatively connected with the internal pacemaker, receives the ECG information sent by the internal pacemaker, and sends the received control instruction to the internal pacemaker.

在一个可能的实现方式中,所述系统还包括处理器,其中,所述处理器包括鉴权单元,所述鉴权单元与所述第二鉴权单元通信连接;In a possible implementation manner, the system further includes a processor, where the processor includes an authentication unit, and the authentication unit is connected in communication with the second authentication unit;

所述处理器,与所述体外控制器通信连接,接收所述体外控制器发送的所述心电信息,并将控制指令发送给所述体外控制器。The processor is communicatively connected with the external controller, receives the ECG information sent by the external controller, and sends a control instruction to the external controller.

在一个可能的实现方式中,所述处理器为云服务器或智能终端。In a possible implementation manner, the processor is a cloud server or an intelligent terminal.

在一个可能的实现方式中,所述处理器包括云服务器和智能终端,所述鉴权单元包括第三鉴权单元和第四鉴权单元,所述第三鉴权单元内置于所述云服务器内,所述第四鉴权单元内置于所述智能终端内,所述第三鉴权单元与所述第四鉴权单元通信连接;In a possible implementation, the processor includes a cloud server and an intelligent terminal, the authentication unit includes a third authentication unit and a fourth authentication unit, and the third authentication unit is built in the cloud server In, the fourth authentication unit is built in the smart terminal, and the third authentication unit is connected in communication with the fourth authentication unit;

所述云服务器,与所述体外控制器和所述智能终端通信连接,接收所述体外控制器发送的心电信息,并发送心脏风险信息给所述智能终端;The cloud server communicates with the in vitro controller and the smart terminal, receives ECG information sent by the in vitro controller, and sends heart risk information to the smart terminal;

所述智能终端,与所述体外控制器通信连接,接收所述心脏风险信息,并发送控制指令给所述体外控制器。The intelligent terminal communicates with the external controller, receives the cardiac risk information, and sends control instructions to the external controller.

在一个可能的实现方式中,所述体内起搏器包括第一天线,所述体外控制器包括第二天线;In a possible implementation manner, the internal pacemaker includes a first antenna, and the external controller includes a second antenna;

所述体外控制器利用所述第二天线,通过电磁感应耦合的方式向所述第一天线提供电能,所述第一天线用于向所述体内起搏器供电。The external controller uses the second antenna to provide electric energy to the first antenna through electromagnetic induction coupling, and the first antenna is used to supply power to the internal pacemaker.

在一个可能的实现方式中,所述第一天线为镁钙合金制成。In a possible implementation manner, the first antenna is made of magnesium-calcium alloy.

在一个可能的实现方式中,所述第一天线外设置有可替换的第一生物保护膜,所述第一生物保护膜根据心脏起搏器的使用年限需求进行更换。In a possible implementation manner, a replaceable first biological protection film is arranged on the outside of the first antenna, and the first biological protection film is replaced according to the service life of the cardiac pacemaker.

在一个可能的实现方式中,所述第一生物保护膜采用聚乳酸乙醇酸、对苯二甲酸乙二醇酯、聚酯纤维或聚醚醚酮制成。In a possible implementation manner, the first biological protection film is made of poly(lactic-co-glycolic acid), ethylene terephthalate, polyester fiber or polyetheretherketone.

在一个可能的实现方式中,所述体内起搏器还包括电极,所述电极与心脏内膜或心肌表面连接,通过电流刺激心肌完成起搏。In a possible implementation manner, the internal pacemaker further includes electrodes, the electrodes are connected to the endocardium or the surface of the myocardium, and stimulate the myocardium to complete pacing through electric current.

在一个可能的实现方式中,所述体内起搏器还包括起搏导线、起搏导线连接器和控制芯片;In a possible implementation manner, the internal pacemaker further includes a pacing lead, a pacing lead connector, and a control chip;

所述起搏导线与所述电极连接,用于接收所述心电信息;The pacing lead is connected to the electrode for receiving the ECG information;

所述控制芯片通过所述起搏导线与所述起搏导线连接器连接,用于接收所述心电信息。The control chip is connected to the pacing lead connector through the pacing lead for receiving the ECG information.

在一个可能的实现方式中,所述起搏导线外设置有可更换的第二生物保护膜,所述第二生物保护膜根据心脏起搏器的使用年限需求进行更换。In a possible implementation manner, a replaceable second biological protection film is arranged on the outside of the pacing lead, and the second biological protection film is replaced according to the service life of the cardiac pacemaker.

在一个可能的实现方式中,所述第二生物保护膜采用聚乳酸乙醇酸、对苯二甲酸乙二醇酯、聚酯纤维或聚醚醚酮制成。In a possible implementation manner, the second biological protection film is made of poly(lactic-co-glycolic acid), ethylene terephthalate, polyester fiber or polyetheretherketone.

在一个可能的实现方式中,所述起搏导线连接器共4只。In a possible implementation manner, there are four pacing wire connectors in total.

在一个可能的实现方式中,所述电极为镁钙合金材料或钛合金材料制成。In a possible implementation manner, the electrode is made of a magnesium-calcium alloy material or a titanium alloy material.

第二方面,本发明提供了一种控制心脏起搏的方法,所述方法包括以下步骤:In a second aspect, the present invention provides a method for controlling cardiac pacing, the method comprising the following steps:

体内起搏器获取心脏的心电信息;The internal pacemaker obtains the ECG information of the heart;

体内起搏器和体外控制器之间进行鉴权认证;Authentication between the internal pacemaker and the external controller;

待鉴权认证通过后,体外控制器接收体内起搏器发送的所述心电信息,并将接收的控制指令发送给所述体内起搏器,用以控制心脏起搏。After the authentication is passed, the external controller receives the ECG information sent by the pacemaker in the body, and sends the received control command to the pacemaker in the body to control cardiac pacing.

在一个可能的实现方式中,体内起搏器和体外控制器之间进行鉴权认证过程,包括:In a possible implementation manner, an authentication process is performed between the internal pacemaker and the external controller, including:

所述体内控制器创建设备,并将所述设备的钥匙和密码发送给所述体内起搏器;the in vivo controller creates a device and sends the device's key and password to the in vivo pacemaker;

所述体内起搏器根据接收的钥匙和密码进行预配,并将预配后的登录信息返回给所述体外控制器;The internal pacemaker performs preconfiguration according to the received key and password, and returns the preconfigured login information to the external controller;

所述体外控制器根据返回的所述登录信息进行认证。The in vitro controller performs authentication according to the returned login information.

在一个可能的实现方式中,所述方法还包括:In a possible implementation, the method also includes:

处理器与体外控制器之间进行鉴权认证;Authentication and authentication between the processor and the in vitro controller;

待鉴权认证通过后,处理器接收所述体外控制器发送的所述心电信息,并将控制指令发送给所述体外控制器。After the authentication is passed, the processor receives the ECG information sent by the external controller, and sends a control instruction to the external controller.

在一个可能的实现方式中,所述处理器为云服务器或智能终端。In a possible implementation manner, the processor is a cloud server or an intelligent terminal.

在一个可能的实现方式中,所述处理器和所述体外控制器之间通过X509证书进行TLS握手,用以进行鉴权认证。在一个可能的实现方式中,所述方法还包括:所述处理器包括云服务器和智能终端,所述处理器与体外控制器间进行鉴权认证,待鉴权认证通过后,处理器接收所述体外控制器发送的所述心电信息,并将控制指令发送给所述体外控制器,包括:In a possible implementation manner, a TLS handshake is performed between the processor and the in vitro controller through an X509 certificate for authentication. In a possible implementation manner, the method further includes: the processor includes a cloud server and an intelligent terminal, performing authentication between the processor and the in vitro controller, and after the authentication is passed, the processor receives the The ECG information sent by the external controller, and control instructions are sent to the external controller, including:

所述云服务器分别与所述体外控制器和所述智能终端进行鉴权认证;The cloud server performs authentication with the in vitro controller and the intelligent terminal respectively;

待鉴权认证均通过后,所述云服务器接收所述体外控制器发送的心电信息,并发送心脏风险信息给所述智能终端;After the authentication and authentication are all passed, the cloud server receives the ECG information sent by the in vitro controller, and sends heart risk information to the smart terminal;

所述体外控制器与所述智能终端之间进行鉴权认证;performing authentication between the in vitro controller and the intelligent terminal;

待鉴权认证通过后,所述智能终端接收所述心脏风险信息,并发送控制指令给所述体外控制器。After the authentication is passed, the smart terminal receives the heart risk information, and sends a control command to the in vitro controller.

在一个可能的实现方式中,智能终端和云服务器之间进行鉴权认证过程,包括:In a possible implementation manner, an authentication process is performed between the smart terminal and the cloud server, including:

所述智能终端将账号和密码发送给所述云服务器;The smart terminal sends the account number and password to the cloud server;

若所述账号存在所述云服务器的数据库中,则所述云服务器将所述密码的SHA256值与数据库中的passwd字段值对比是否一致;If the account number exists in the database of the cloud server, whether the cloud server compares the SHA256 value of the password with the passwd field value in the database is consistent;

若一致,则所述云服务器创建一个session对象,并将session_id用setCookie传输给浏览器;If consistent, the cloud server creates a session object, and transmits the session_id to the browser with setCookie;

若浏览器确认setCookie字段存在,则所述智能终端向所述云服务器发送携带Cookie s_id的http请求;If the browser confirms that the setCookie field exists, the smart terminal sends an http request carrying the Cookie s_id to the cloud server;

所述云服务器接收所述http请求并进行确认,确认通过,则获取智能终端信息。The cloud server receives the http request and confirms it. If the confirmation is passed, the smart terminal information is acquired.

第三方面,本发明提供了一种电子设备,包括处理器、通信接口、存储器和通信总线,其中,处理器,通信接口,存储器通过通信总线完成相互间的通信;In a third aspect, the present invention provides an electronic device, including a processor, a communication interface, a memory, and a communication bus, wherein the processor, the communication interface, and the memory complete communication with each other through the communication bus;

存储器,用于存放计算机程序;memory for storing computer programs;

处理器,用于执行存储器上所存放的程序时,实现如第二方面任一项实施例的方法。The processor is configured to implement the method according to any one embodiment of the second aspect when executing the program stored in the memory.

第四方面,本发明提供了一种计算机可读存储介质,其上存储有计算机程序,计算机程序被处理器执行时实现如第二方面任一项实施例的方法。In a fourth aspect, the present invention provides a computer-readable storage medium, on which a computer program is stored, and when the computer program is executed by a processor, the method according to any one of the embodiments of the second aspect is implemented.

本发明实施例提供的上述技术方案与现有技术相比具有如下优点:Compared with the prior art, the technical solution provided by the embodiments of the present invention has the following advantages:

本发明实施例提供的一种心脏起搏器系统,包括体外控制器及体内起搏器,其中,所述体内起搏器内设置有第一鉴权单元,所述体外控制器内设置有第二鉴权单元,所述第一鉴权单元和所述第二鉴权单元通信连接;所述体内起搏器,用于获取心脏的心电信息;所述体外控制器,与所述体内起搏器通信连接,接收所述体内起搏器发送的所述心电信息,并将接收的控制指令发送给所述体内起搏器。本发明提供的系统,具备双向鉴权认证和实时心电监测的能力,同时具备云连接和远程监测和诊疗的功能。A cardiac pacemaker system provided by an embodiment of the present invention includes an external controller and an internal pacemaker, wherein the internal pacemaker is provided with a first authentication unit, and the external controller is provided with a second authentication unit. Two authentication units, the first authentication unit and the second authentication unit are connected in communication; the internal pacemaker is used to obtain the ECG information of the heart; the external controller is connected to the internal pacemaker connected to a pacemaker for communication, receiving the electrocardiographic information sent by the pacemaker in the body, and sending the received control instruction to the pacemaker in the body. The system provided by the present invention has the capabilities of two-way authentication and real-time ECG monitoring, and also has the functions of cloud connection and remote monitoring and diagnosis and treatment.

附图说明Description of drawings

图1为本发明实施例提供的心脏起搏器系统结构示意图之一;Fig. 1 is one of the structural schematic diagrams of the cardiac pacemaker system provided by the embodiment of the present invention;

图2为本发明实施例提供的心脏起搏器系统结构示意图之二;Fig. 2 is the second structural diagram of the cardiac pacemaker system provided by the embodiment of the present invention;

图3为本发明实施例提供的心脏起搏器系统结构示意图之三;Fig. 3 is the third structural diagram of the cardiac pacemaker system provided by the embodiment of the present invention;

图4为本发明实施例提供的体内起搏器的俯视结构示意图;FIG. 4 is a schematic top view of the internal pacemaker provided by the embodiment of the present invention;

图5为本发明实施例提供的体内起搏器的侧视结构示意图;FIG. 5 is a schematic side view of the internal pacemaker provided by the embodiment of the present invention;

图6为本发明实施例提供的控制心脏起搏的方法流程示意图之一;Fig. 6 is one of the flow charts of the method for controlling cardiac pacing provided by the embodiment of the present invention;

图7为体外控制器与体内起搏器之间的鉴权认证过程示意图;Fig. 7 is a schematic diagram of the authentication process between the external controller and the internal pacemaker;

图8为本发明实施例提供的控制心脏起搏的方法流程示意图之二;Fig. 8 is the second schematic flow diagram of the method for controlling cardiac pacing provided by the embodiment of the present invention;

图9为外控制器与处理器之间的鉴权认证过程示意图;Fig. 9 is a schematic diagram of the authentication process between the external controller and the processor;

图10为本发明实施例提供的控制心脏起搏的方法流程示意图之三;Fig. 10 is the third schematic flow chart of the method for controlling cardiac pacing provided by the embodiment of the present invention;

图11为智能终端与云服务器之间的鉴权认证过程示意图;Fig. 11 is a schematic diagram of the authentication process between the smart terminal and the cloud server;

图12为本发明实施例提供一种电子设备结构示意图。FIG. 12 is a schematic structural diagram of an electronic device provided by an embodiment of the present invention.

具体实施方式detailed description

为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments It is a part of embodiments of the present invention, but not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

为便于对本发明实施例的理解,下面将结合附图以具体实施例做进一步的解释说明,实施例并不构成对本发明实施例的限定。In order to facilitate the understanding of the embodiments of the present invention, further explanations will be given below with specific embodiments in conjunction with the accompanying drawings, which are not intended to limit the embodiments of the present invention.

需要说明的是,在本文中,诸如“第一”和“第二”等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。而且,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。在没有更多限制的情况下,由语句“包括一个……”限定的要素,并不排除在包括要素的过程、方法、物品或者设备中还存在另外的相同要素。It should be noted that in this article, relative terms such as "first" and "second" are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply these No such actual relationship or order exists between entities or operations. Furthermore, the term "comprises", "comprises" or any other variation thereof is intended to cover a non-exclusive inclusion such that a process, method, article, or apparatus comprising a set of elements includes not only those elements, but also includes elements not expressly listed. other elements of or also include elements inherent in such a process, method, article, or apparatus. Without further limitations, an element defined by the phrase "comprising a ..." does not preclude the presence of additional identical elements in the process, method, article, or apparatus that includes the element.

在本发明中,“在一个示例中”用来表示“用作例子、例证或说明”。本发明中被描述为“在一个示例中”的任何实施例不一定被解释为比其它实施例更优选或更具优势。为了使本领域任何技术人员能够实现和使用本发明,给出了以下描述。在以下描述中,为了解释的目的而列出了细节。应当明白的是,本领域普通技术人员可以认识到,在不使用这些特定细节的情况下也可以实现本发明。在其它实例中,不会对公知的结构和过程进行详细阐述,以避免不必要的细节使本发明的描述变得晦涩。因此,本发明并非旨在限于所示的实施例,而是与符合本发明所公开的原理和特征的最广范围相一致。In the present invention, "in an example" is used to mean "serving as an example, illustration or illustration". Any embodiment described herein as "in one example" is not necessarily to be construed as preferred or advantageous over other embodiments. The following description is given to enable any person skilled in the art to make and use the invention. In the following description, details are set forth for purposes of explanation. It should be understood that one of ordinary skill in the art would recognize that the present invention may be practiced without the use of these specific details. In other instances, well-known structures and procedures are not described in detail to avoid obscuring the description of the present invention with unnecessary detail. Thus, the present invention is not intended to be limited to the embodiments shown but is to be accorded the widest scope consistent with the principles and features disclosed herein.

针对背景技术中所提及的技术问题,本发明实施例提供了一种心脏起搏器系统,具体参见图1所示,图1为本发明提供的一种心脏起搏器系统结构示意图之一,如图1所示,心脏起搏器系统包括:体内起搏器11和体外控制器12,其中,体内起搏器内设置有第一鉴权单元111,体外控制器内设置有第二鉴权单元121,第一鉴权单元111和第二鉴权单元121通信连接;Aiming at the technical problems mentioned in the background technology, the embodiment of the present invention provides a cardiac pacemaker system, as shown in Fig. 1 for details, Fig. 1 is one of the schematic structural diagrams of a cardiac pacemaker system provided by the present invention , as shown in Figure 1, the cardiac pacemaker system includes: an internal pacemaker 11 and an external controller 12, wherein a first authentication unit 111 is arranged in the internal pacemaker, and a second authentication unit 111 is arranged in the external controller. Authorization unit 121, the first authentication unit 111 and the second authentication unit 121 are connected in communication;

所述体内起搏器11,用于获取心脏的心电信息;The internal pacemaker 11 is used to obtain the electrocardiographic information of the heart;

所述体外控制器12,与所述体内起搏器11通信连接,接收所述体内起搏器11发送的所述心电信息,并将接收的控制指令发送给所述体内起搏器11。The external controller 12 is communicatively connected with the internal pacemaker 11 , receives the ECG information sent by the internal pacemaker 11 , and sends the received control instruction to the internal pacemaker 11 .

在一个示例中,如图2所示,图2为本发明提供的一种心脏起搏器系统结构示意图之二,如图2所示,该系统还包括处理器13,所述处理器13包括鉴权单元131,所述鉴权单元131与所述第二鉴权单元121通信连接;In one example, as shown in FIG. 2, FIG. 2 is the second structural diagram of a cardiac pacemaker system provided by the present invention. As shown in FIG. 2, the system further includes a processor 13, and the processor 13 includes An authentication unit 131, the authentication unit 131 is connected in communication with the second authentication unit 121;

所述处理器13,与所述体外控制器12通信连接,接收所述体外控制器12发送的所述心电信息,并将控制指令发送给所述体外控制器12。The processor 13 communicates with the external controller 12 , receives the ECG information sent by the external controller 12 , and sends a control command to the external controller 12 .

在一个可能的实施方式中,处理器13为云服务器或智能终端。需要指出的是,当处理器为智能终端时,可以包括一个智能终端,也可以包括第一智能终端和第二智能终端,若同时包括第一智能终端和第二智能终端,则其中一个是医护人员使用,一个是心脏起搏器的佩戴者使用。无论是几个智能终端,其内都设置有鉴权单元,与其他结构之间进行通信连接。In a possible implementation manner, the processor 13 is a cloud server or an intelligent terminal. It should be pointed out that when the processor is an intelligent terminal, it may include one intelligent terminal, and may also include a first intelligent terminal and a second intelligent terminal. If both the first intelligent terminal and the second intelligent terminal are included, one of them is a medical Personnel use, one is for pacemaker wearers. No matter it is several intelligent terminals, an authentication unit is arranged in it, and communicates with other structures.

在另外一个示例中,如图3所示,图3为本发明提供的一种心脏起搏器系统结构示意图之三,如图3所示,处理器13包括云服务器14和智能终端15,所述鉴权单元131包括第三鉴权单元141和第四鉴权单元151,所述第三鉴权单元141内置于所述云服务器14内,所述第四鉴权单元151内置于所述智能终端15内,所述第三鉴权单元141与所述第四鉴权单元151通信连接;In another example, as shown in FIG. 3, FIG. 3 is a third structural diagram of a cardiac pacemaker system provided by the present invention. As shown in FIG. 3, the processor 13 includes a cloud server 14 and an intelligent terminal 15, so The authentication unit 131 includes a third authentication unit 141 and a fourth authentication unit 151, the third authentication unit 141 is built in the cloud server 14, and the fourth authentication unit 151 is built in the smart In the terminal 15, the third authentication unit 141 communicates with the fourth authentication unit 151;

所述云服务器14,与所述体外控制器12和所述智能终端15通信连接,接收所述体外控制器12发送的心电信息,并发送心脏风险信息给所述智能终端15;The cloud server 14 is communicatively connected with the external controller 12 and the intelligent terminal 15, receives the ECG information sent by the external controller 12, and sends heart risk information to the intelligent terminal 15;

所述智能终端15,与所述体外控制器12通信连接,接收所述心脏风险信息,并发送控制指令给所述体外控制器12。The intelligent terminal 15 communicates with the external controller 12 , receives the heart risk information, and sends control instructions to the external controller 12 .

通过上述的描述可知,体外控制器12具备周期性的向云服务器14和智能终端15发送心脏的心电信息的功能,即发送心电监测信息的功能,同时具备接收从云服务器14和智能终端15的控制指令,如心脏起搏指令和配置参数等能力。It can be seen from the above description that the in vitro controller 12 has the function of periodically sending the ECG information of the heart to the cloud server 14 and the smart terminal 15, that is, the function of sending ECG monitoring information, and at the same time has the function of receiving the ECG information from the cloud server 14 and the smart terminal 15. 15 control commands, such as cardiac pacing commands and configuration parameters and other capabilities.

另外,云服务器14可以接收体外控制器12发送的心电信息,开展在线实时风险预警,将识别到的心脏风险信息主动推送给体外控制器12、智能终端15,包括用户绑定的医院/医生的信息系统中。In addition, the cloud server 14 can receive the ECG information sent by the external controller 12, carry out online real-time risk warning, and actively push the identified cardiac risk information to the external controller 12, the intelligent terminal 15, including the hospital/doctor bound by the user. in the information system.

智能终端15可以主动/被动获取目标患者的心电实时监测和历史监测信息,可根据心电监测信息主动实施心脏起搏或设置心脏起搏策略。The smart terminal 15 can actively/passively acquire the target patient's ECG real-time monitoring and historical monitoring information, and can actively implement cardiac pacing or set cardiac pacing strategies according to the ECG monitoring information.

本发明提供的心脏起搏器系统,具备双向鉴权认证和实时心电监测的能力,同时具备云连接和远程监测和诊疗的功能。The cardiac pacemaker system provided by the present invention has the capabilities of two-way authentication and real-time ECG monitoring, and also has the functions of cloud connection and remote monitoring and diagnosis and treatment.

在一个示例中,本发明还提供了一种体内起搏器的结构示意图,具体详见图4和图5所示,其中,图4为本发明实施例提供的体内起搏器的俯视结构示意图,图5为本发明实施例提供的体内起搏器的侧视结构示意图。In one example, the present invention also provides a schematic structural diagram of an internal pacemaker, as shown in Figure 4 and Figure 5 for details, wherein Figure 4 is a top view structural schematic diagram of an internal pacemaker provided by an embodiment of the present invention , FIG. 5 is a side view schematic diagram of the internal pacemaker provided by the embodiment of the present invention.

如图4所示,体内起搏器包括第一天线1,体外控制器包括第二天线(未标注)。体外控制器12利用第二天线,通过电磁感应耦合的方式向第一天线1提供电能,第一天线1用于向体内起搏器11供电,本发明采用无源无线供电的方式,使得心脏起搏器的寿命不再受限于电池,永久心脏起搏器具有20年以上的使用寿命,且由于采用无电池设计,整机重量大幅下降,患者感受好。As shown in Fig. 4, the internal pacemaker includes a first antenna 1, and the external controller includes a second antenna (not labeled). The external controller 12 uses the second antenna to provide electric energy to the first antenna 1 through electromagnetic induction coupling. The first antenna 1 is used to supply power to the pacemaker 11 in the body. The present invention adopts a passive wireless power supply method to make the heart start The life of the pacemaker is no longer limited by the battery. The permanent pacemaker has a service life of more than 20 years, and due to the battery-free design, the weight of the whole machine is greatly reduced, and the patient feels better.

具体地,体外控制器12具备向体内心脏起搏器11无线供电和与之通信的能力,考虑电磁场的衰减,其射频频率范围应为2MHz~50MHz。考虑电磁兼容性以及体内心脏起搏器11的功耗,射频功率范围应为50mW~1000mW。Specifically, the external controller 12 has the capability of wirelessly supplying power to and communicating with the internal cardiac pacemaker 11, and considering the attenuation of the electromagnetic field, its radio frequency range should be 2MHz-50MHz. Considering the electromagnetic compatibility and the power consumption of the pacemaker 11 in the body, the radio frequency power range should be 50mW˜1000mW.

另外,考虑辐射安全、抗干扰、患者舒适度等条件,第一天线1的外形可采用圆形、方形或三维立体结构,等效截面积采用如下工程公式估算:In addition, considering radiation safety, anti-interference, patient comfort and other conditions, the shape of the first antenna 1 can adopt a circular, square or three-dimensional structure, and the equivalent cross-sectional area is estimated by the following engineering formula:

S≈H2/(25*P)S≈H 2 /(25*P)

其中S为第一天线1的等效截面积(单位为mm2),H为第一天线1与体表的距离(单位为mm),P为体外控制器13的射频功率(单位为W)。Wherein S is the equivalent cross-sectional area of the first antenna 1 (unit is mm 2 ), H is the distance between the first antenna 1 and the body surface (unit is mm), and P is the radio frequency power of the external controller 13 (unit is W) .

为使得第一天线1在人体内具有可控降解的能力,第一天线4采用镁钙合金材质,通过控制合金中镁钙元素的比例调整完全降解的时间。第一天线1的完全可降解时间控制在3个月时间左右,第一天线1的阻抗控制在50Ω±0.1Ω范围内。In order to enable the first antenna 1 to have a controllable degradation capability in the human body, the first antenna 4 is made of a magnesium-calcium alloy, and the complete degradation time is adjusted by controlling the ratio of the magnesium-calcium element in the alloy. The complete degradability time of the first antenna 1 is controlled within about 3 months, and the impedance of the first antenna 1 is controlled within the range of 50Ω±0.1Ω.

为保护体内起搏器11的结构和电路不受生物环境的腐蚀,第一天线1外设置有第一生物保护膜2,第一生物保护膜2采用聚乳酸乙醇酸、对苯二甲酸乙二醇酯、聚酯纤维或聚醚醚酮制成,降解前后应对生物体无毒无害,柔韧性好,人体感受舒适。具体地,当适用于临时心脏起搏器场景时,一般选用聚乳酸乙醇酸材料,通过控制保护膜的厚度等参数控制降解时间,一般的厚度范围为10um~1mm,完全降解时间一般在1周~3个月。当适用于永久心脏起搏器时,一般采用对苯二甲酸乙二醇酯或聚酯纤维或聚醚醚酮材料。本发明提供的心脏起搏器使用方便,这是因为其第一天线外设置的第一生物保护膜是可更换的,根据心脏起搏器的使用年限需求进行更换,比如,当需要使用永久心脏起搏器时,可选择由对苯二甲酸乙二醇酯或聚酯纤维或聚醚醚酮材料制成的第一生物保护膜,当需要使用临时心脏起搏器时,则直接将由对苯二甲酸乙二醇酯或聚酯纤维或聚醚醚酮材料制成的第一生物保护膜更换为由聚乳酸乙醇酸材料制成的的第一生物保护膜,换句话说,第一生物保护膜是可以随时更换的,在手术过程种,根据用户需要使用的心脏起搏器的年限需求,直接选择对应材料制成的第一生物保护膜设置在第一天线外。In order to protect the structure and circuit of the pacemaker 11 in the body from being corroded by the biological environment, a first biological protective film 2 is arranged outside the first antenna 1, and the first biological protective film 2 is made of polylactic acid glycolic acid, ethylene terephthalate Made of alcohol ester, polyester fiber or polyether ether ketone, it is non-toxic and harmless to organisms before and after degradation, has good flexibility and is comfortable for the human body. Specifically, when it is suitable for temporary cardiac pacemaker scenarios, polylactic acid glycolic acid materials are generally used, and the degradation time is controlled by controlling parameters such as the thickness of the protective film. The general thickness range is 10um to 1mm, and the complete degradation time is generally within 1 week. ~3 months. Ethylene terephthalate or polyester or polyether ether ketone materials are generally used when suitable for permanent pacemakers. The cardiac pacemaker provided by the present invention is easy to use, because the first biological protective film arranged outside the first antenna is replaceable, and can be replaced according to the service life requirements of the cardiac pacemaker, for example, when a permanent cardiac For pacemakers, you can choose the first bioprotective film made of ethylene terephthalate or polyester fiber or polyetheretherketone material. The first bioprotective film made of ethylene glycol diformate or polyester fiber or polyether ether ketone material is replaced by the first bioprotective film made of polylactic acid glycolic acid material, in other words, the first bioprotective film The membrane can be replaced at any time. During the operation, according to the age requirements of the cardiac pacemaker that the user needs to use, the first bioprotective membrane made of the corresponding material is directly selected and placed outside the first antenna.

在一个示例中,体内起搏器11包括基底3,对电路起支撑作用,具有一定的强度和柔韧性。具体地,基底3采用亲水型聚氨酯制成,厚度在20um~100um之间,基底之上通过半导体溅射工艺实现所需的集成电路。In one example, the internal pacemaker 11 includes a substrate 3, which supports the circuit and has certain strength and flexibility. Specifically, the substrate 3 is made of hydrophilic polyurethane with a thickness between 20um and 100um, and the required integrated circuit is realized on the substrate by semiconductor sputtering process.

在一个示例中,体内起搏器11还包括电极4,电极4与心脏内膜或心肌表面连接,与心脏形成电回路,通过电流刺激心肌完成起搏。在不同的心脏起搏器中,电极4的材料选择有所不同,在临时心脏起搏器中,电极4选用可降解的镁钙合金材料制作,在永久心脏起搏器中,选择不可降解的钛合金制作。In one example, the internal pacemaker 11 further includes an electrode 4, which is connected to the endocardium or the surface of the myocardium, forms an electrical circuit with the heart, and stimulates the myocardium to complete pacing. In different cardiac pacemakers, the material selection of electrode 4 is different. In temporary cardiac pacemakers, electrode 4 is made of degradable magnesium-calcium alloy materials. In permanent cardiac pacemakers, non-degradable Made of titanium alloy.

在一个示例中,体内起搏器还包括起搏导线5、起搏导线连接器6和控制芯片7,起搏导线5与电极4连接,用于接收心电信息;控制芯片7通过起搏导线4与起搏导线连接器6连接,用于接收心电信息。In one example, the pacemaker in the body also includes a pacing lead 5, a pacing lead connector 6 and a control chip 7, the pacing lead 5 is connected to the electrode 4 for receiving ECG information; the control chip 7 passes through the pacing lead 4 is connected with the pacing wire connector 6 for receiving electrocardiographic information.

其中,控制芯片7在基底之上一般可通过薄膜集成电路工艺制成,厚度小于50um,具备整流、鉴权、通信控制、脉冲控制以及心电监测的能力。仅允许鉴权后的触发心脏起搏脉冲。Among them, the control chip 7 can generally be made on the substrate by thin film integrated circuit technology, the thickness is less than 50um, and has the capabilities of rectification, authentication, communication control, pulse control and ECG monitoring. Only authenticated triggered cardiac pacing pulses are allowed.

为保护起搏导线5,在起搏导线5外设置有第二生物保护膜8,第二生物保护膜8采用聚乳酸乙醇酸、对苯二甲酸乙二醇酯、聚酯纤维或聚醚醚酮制成。需要指出的是,第二生物保护膜8与所述第一生物保护膜2的材质一致。同时,为使得心脏起搏器使用方便,同第一生物保护膜一样,第二生物保护膜也是可更换的,根据心脏起搏器的使用年限需求进行更换,比如,当需要使用永久心脏起搏器时,可选择由对苯二甲酸乙二醇酯或聚酯纤维或聚醚醚酮材料制成的第二生物保护膜,当需要使用临时心脏起搏器时,则直接将由对苯二甲酸乙二醇酯或聚酯纤维或聚醚醚酮材料制成的第二生物保护膜更换为由聚乳酸乙醇酸材料制成的的第二生物保护膜。换句话说,第二生物保护膜是可以随时更换的,在手术过程种,根据用户需要使用的心脏起搏器的年限需要,直接选择对应材料制成的第二生物保护膜设置在起搏导线外。In order to protect the pacing lead 5, a second biological protective film 8 is arranged outside the pacing lead 5, and the second biological protective film 8 is made of polylactic acid glycolic acid, ethylene terephthalate, polyester fiber or polyether ether Made with ketones. It should be pointed out that the material of the second biological protection film 8 is consistent with that of the first biological protection film 2 . At the same time, in order to make the pacemaker easy to use, like the first biological protective film, the second biological protective film is also replaceable, and it can be replaced according to the service life of the pacemaker, for example, when a permanent cardiac pacemaker is required When using a pacemaker, you can choose the second biological protection film made of ethylene terephthalate or polyester fiber or polyetheretherketone material. When you need to use a temporary pacemaker, you can directly use terephthalic acid The second biological protection film made of ethylene glycol ester or polyester fiber or polyetheretherketone material is replaced by the second biological protection film made of polylactic acid glycolic acid material. In other words, the second biological protective film can be replaced at any time. During the operation, according to the age of the pacemaker that the user needs to use, the second biological protective film made of the corresponding material is directly selected and placed on the pacing lead. outside.

起搏导线5连接电极4和体内心脏起搏器11的主体,传输起搏电流和心电监测信号。起搏导线5材料的选择需要与电极4材料的选择匹配,在临时心脏起搏器应用场景中,起搏导线材料应选择镁钙合金材料制作,在永久心脏起搏器应用场景中,起搏导线材料应选择钛合金材料制作。因此,作为临时心脏起搏器,患者术后无需等待拔除起搏导线即可出院,出院后在一定时间内仍能够得到健康监护。The pacing wire 5 connects the electrode 4 and the main body of the cardiac pacemaker 11 in the body, and transmits pacing current and ECG monitoring signals. The choice of material for the pacing wire 5 needs to match the selection of the material for the electrode 4. In the application scenario of a temporary cardiac pacemaker, the material of the pacing wire should be made of magnesium-calcium alloy. In the application scenario of a permanent cardiac pacemaker, the pacing wire The wire material should be made of titanium alloy. Therefore, as a temporary cardiac pacemaker, patients can be discharged from the hospital after surgery without waiting for the pacing lead to be removed, and they can still receive health care for a certain period of time after discharge.

起搏导线4的合金比例与第一天线1一致,但应由多股更细的合金丝合成,股数不少于10股,总直径不大于1mm。The alloy ratio of the pacing wire 4 is the same as that of the first antenna 1, but it should be composed of multiple thinner alloy wires, the number of strands is not less than 10 strands, and the total diameter is not greater than 1mm.

通过上述的描述可知,本发明中的体内起搏器中的各部件采用可降解的材料,因此,本发明具备通过更换生物保护膜以及起搏导线和电极的方式切换临时心脏起搏器和永久心脏起搏器的能力。It can be seen from the above description that each part in the internal pacemaker of the present invention adopts degradable materials, therefore, the present invention has the ability to switch between temporary cardiac pacemaker and permanent cardiac pacemaker by replacing the biological protective film, pacing wire and electrodes Pacemaker capabilities.

在本发明中,优选地,具备4只起搏导线连接器6,使得体内起搏器具备双腔起搏的能力,可以解决房室传导阻滞的问题,实现左右心房心室同步起搏。在实际应用过程中,医生可根据单腔起搏或双腔起搏的需求自主的选择连接2根或4根起搏导线连接器6,在进行单腔起搏时,选择连接2根起搏导线连接器6,剩余的2根可以封闭处理。In the present invention, preferably, four pacing wire connectors 6 are provided, so that the internal pacemaker has the capability of dual-chamber pacing, which can solve the problem of atrioventricular block and realize synchronous pacing of left and right atrium and ventricle. In practical application, doctors can choose to connect 2 or 4 pacing wire connectors 6 independently according to the needs of single-chamber pacing or dual-chamber pacing. Wire connector 6, the remaining 2 can be closed for processing.

本发明实施例提供心脏起搏器系统,包括体外控制器及体内起搏器,其中,所述体内起搏器内设置有第一鉴权单元,所述体外控制器内设置有第二鉴权单元,所述第一鉴权单元和所述第二鉴权单元通信连接;所述体内起搏器,用于获取心脏的心电信息;所述体外控制器,与所述体内起搏器通信连接,接收所述体内起搏器发送的所述心电信息,并将接收的控制指令发送给所述体内起搏器。本发明提供的系统,具备通过云服务器实时监测和分析患者健康状态的能力,将大大改善患者的愈后健康管理,提高患者的生活和健康水平。An embodiment of the present invention provides a cardiac pacemaker system, including an external controller and an internal pacemaker, wherein, the internal pacemaker is provided with a first authentication unit, and the external controller is provided with a second authentication unit. unit, the first authentication unit and the second authentication unit are connected in communication; the internal pacemaker is used to obtain the ECG information of the heart; the external controller communicates with the internal pacemaker connected to receive the ECG information sent by the internal pacemaker, and send the received control instruction to the internal pacemaker. The system provided by the present invention has the ability to monitor and analyze the patient's health status in real time through the cloud server, which will greatly improve the patient's post-cure health management and improve the patient's life and health level.

以上,为本发明所提供的心脏起搏器系统实施例,下文中则介绍说明本发明所提供的控制心脏起搏的方法实施例,具体参见如下。The above is the embodiment of the cardiac pacemaker system provided by the present invention, and the following describes the embodiment of the method for controlling cardiac pacing provided by the present invention. For details, refer to the following.

图6为本发明实施例提供的一种控制心脏起搏的方法流程示意图,控制心脏起搏的方法应用于如上述实施例中的心脏起搏器系统,如图6所示,该方法包括以下步骤:Fig. 6 is a schematic flowchart of a method for controlling cardiac pacing provided by an embodiment of the present invention. The method for controlling cardiac pacing is applied to the cardiac pacemaker system in the above-mentioned embodiment. As shown in Fig. 6, the method includes the following step:

步骤110,体内起搏器获取心脏的心电信息。Step 110, the internal pacemaker obtains the ECG information of the heart.

步骤120,体内起搏器和体外控制器之间进行鉴权认证。Step 120, authentication is performed between the internal pacemaker and the external controller.

步骤130,待鉴权认证通过后,体外控制器接收体内起搏器发送的所述心电信息,并将接收的控制指令发送给所述体内起搏器,用以控制心脏起搏。Step 130, after the authentication is passed, the external controller receives the ECG information sent by the internal pacemaker, and sends the received control command to the internal pacemaker to control cardiac pacing.

下面简单介绍体外控制器与体内起搏器之间的鉴权认证过程,具体的,如图7所示,体外控制器与体内起搏器之间的鉴权认证过程为:体外控制器创建设备,并将钥匙和密码发送给体内起搏器,体内起搏器根据接收的钥匙和密码进行预配,然后返回一个三元组的登录信息给体外控制器,体外控制器根据登录信息进行验证,若验证通过,则体内起搏器将其相关数据发送给体外控制器,体外控制器根据接收到的相关数据,发送相关指令给体内起搏器进行执行。The following briefly introduces the authentication process between the external controller and the internal pacemaker. Specifically, as shown in Figure 7, the authentication process between the external controller and the internal pacemaker is: the external controller creates a device , and send the key and password to the internal pacemaker, the internal pacemaker performs preconfiguration according to the received key and password, and then returns a triplet of login information to the external controller, and the external controller performs verification according to the login information, If the verification is passed, the internal pacemaker sends its relevant data to the external controller, and the external controller sends relevant instructions to the internal pacemaker for execution according to the received relevant data.

在一个示例中,图8为本发明实施例提供的控制心脏起搏的方法流程示意图之二,如图8所示,控制心脏起搏的方法还包括:In one example, FIG. 8 is a second schematic flow diagram of a method for controlling cardiac pacing provided by an embodiment of the present invention. As shown in FIG. 8 , the method for controlling cardiac pacing further includes:

步骤210,处理器与体外控制器之间进行鉴权认证。Step 210, authentication is performed between the processor and the in vitro controller.

步骤220,待鉴权认证通过后,处理器接收所述体外控制器发送的所述心电信息,并将控制指令发送给所述体外控制器。Step 220, after the authentication is passed, the processor receives the ECG information sent by the external controller, and sends a control instruction to the external controller.

在一个可能的实现方式中,处理器为云服务器或智能终端。下面简单介绍体外控制器与处理器之间的鉴权认证过程,如图9所示,体外控制器与处理器之间的鉴权认证过程为:处理器和体外控制器之间通过X509证书进行TLS握手,进行相互认证,处理器验证了IoTHuB,而体外控制器验证了设备,处理器向体外控制器传输了数据,而体外控制器向处理器传输了配置信号或控制信号。In a possible implementation manner, the processor is a cloud server or an intelligent terminal. The following briefly introduces the authentication and authentication process between the in vitro controller and the processor. As shown in Figure 9, the authentication and authentication process between the in vitro controller and the processor is as follows: between the processor and the in vitro controller through the X509 certificate TLS handshake for mutual authentication, the processor authenticates the IoTHuB and the out-of-body controller authenticates the device, the processor transmits data to the out-of-body controller, and the out-of-body controller transmits configuration or control signals to the processor.

在一个示例中,处理器包括云服务器和智能终端。图10为本发明实施例提供的控制心脏起搏的方法流程示意图之三,如图10所示,所述处理器与体外控制器间进行鉴权认证,待鉴权认证通过后,处理器接收所述体外控制器发送的所述心电信息,并将控制指令发送给所述体外控制器,包括:In one example, the processor includes a cloud server and a smart terminal. Fig. 10 is the third schematic flow diagram of the method for controlling cardiac pacing provided by the embodiment of the present invention. As shown in Fig. 10 , authentication is performed between the processor and the in vitro controller. The ECG information sent by the in vitro controller, and control instructions sent to the in vitro controller, including:

步骤310,所述云服务器分别与所述体外控制器和所述智能终端进行鉴权认证;Step 310, the cloud server performs authentication with the in vitro controller and the smart terminal respectively;

步骤320,待鉴权认证均通过后,所述云服务器接收所述体外控制器发送的心电信息,并发送心脏风险信息给所述智能终端;Step 320, after the authentication is passed, the cloud server receives the ECG information sent by the in vitro controller, and sends heart risk information to the smart terminal;

步骤330,所述体外控制器与所述智能终端之间进行鉴权认证;Step 330, performing authentication between the in vitro controller and the smart terminal;

步骤340,待鉴权认证通过后,所述智能终端接收所述心脏风险信息,并发送控制指令给所述体外控制器。Step 340, after the authentication is passed, the smart terminal receives the heart risk information, and sends a control command to the in vitro controller.

下面简单介绍智能终端与云服务器之间的鉴权认证过程,如图11所示,智能终端与云服务器之间的鉴权认证过程:用户通过智能终端第一次访问时体外控制器时,智能终端将用户的账号和密码传送给云服务器,云服务器检测数据库中是否存在该账号,若存在该账号,则将该账号的密码的SHA256值与数据库中的passwd字段值进行对比,若一致,则校验通过,然后云服务器创建一个session对象,并将session_id用setCookie传输给浏览器,浏览器确认setCookie字段是否存在,若存在,则智能终端登录成功,并向云服务器发送http请求,并携带Cookie s_id,云服务器接收请求并进行确认,若确认通过,则获取用户的智能终端信息,并将用户对应的体内起搏器清单及体内起搏器的相关信息传输给智能终端。其中,图11中的用户的账号和密码仅仅是举例说明,在此不做限定。The following briefly introduces the authentication process between the smart terminal and the cloud server. As shown in Figure 11, the authentication process between the smart terminal and the cloud server: when the user accesses the external controller for the first time through the smart terminal, the smart The terminal transmits the user's account and password to the cloud server, and the cloud server detects whether the account exists in the database. If the account exists, the SHA256 value of the password of the account is compared with the passwd field value in the database. If they are consistent, then After the verification is passed, the cloud server creates a session object and transmits the session_id to the browser using setCookie. The browser confirms whether the setCookie field exists. If it exists, the smart terminal successfully logs in and sends an http request to the cloud server with the cookie s_id, the cloud server receives the request and confirms it. If the confirmation is passed, it obtains the user's smart terminal information, and transmits the user's corresponding internal pacemaker list and related information of the internal pacemaker to the smart terminal. Wherein, the account number and password of the user in FIG. 11 are only for illustration, and are not limited here.

本发明实施例提供的一种控制心脏起搏的方法,体内起搏器获取心脏的心电信息;体内起搏器和体外控制器之间进行鉴权认证;待鉴权认证通过后,体外控制器接收体内起搏器发送的所述心电信息,并将接收的控制指令发送给所述体内起搏器,用以控制心脏起搏。通过该方式,可以实现双向鉴权认证和实时心电监测,并可以云连接和远程监测和诊疗。In the method for controlling cardiac pacing provided by the embodiment of the present invention, the pacemaker in the body obtains the ECG information of the heart; authentication is performed between the pacemaker in the body and the controller outside the body; The device receives the electrocardiographic information sent by the pacemaker in the body, and sends the received control command to the pacemaker in the body to control cardiac pacing. In this way, two-way authentication and real-time ECG monitoring can be realized, as well as cloud connection and remote monitoring and diagnosis and treatment.

如图12所示,本发明实施例提供了一种电子设备,包括处理器111、通信接口112、存储器113和通信总线114,其中,处理器111,通信接口112,存储器113通过通信总线114完成相互间的通信。As shown in FIG. 12 , an embodiment of the present invention provides an electronic device, including a processor 111, a communication interface 112, a memory 113, and a communication bus 114, wherein the processor 111, the communication interface 112, and the memory 113 are completed through the communication bus 114. mutual communication.

存储器113,用于存放计算机程序;Memory 113, used to store computer programs;

在本发明一个实施例中,处理器111,用于执行存储器113上所存放的程序时,实现前述方法实施例提供的控制心脏起搏的方法。In one embodiment of the present invention, the processor 111 is configured to implement the method for controlling cardiac pacing provided by the foregoing method embodiments when executing the program stored in the memory 113 .

本发明实施例还提供了一种计算机可读存储介质,其上存储有计算机程序,计算机程序被处理器执行时实现如前述方法实施例提供的控制心脏起搏的方法。An embodiment of the present invention also provides a computer-readable storage medium, on which a computer program is stored, and when the computer program is executed by a processor, the method for controlling cardiac pacing as provided in the foregoing method embodiments is implemented.

专业人员应该还可以进一步意识到,结合本文中所公开的实施例描述的各示例的单元及算法步骤,能够以电子硬件、计算机软件或者二者的结合来实现,为了清楚地说明硬件和软件的可互换性,在上述说明中已经按照功能一般性地描述了各示例的组成及步骤。这些功能究竟以硬件还是软件方式来执行,取决于技术方案的特定应用和设计约束条件。专业技术人员可以对每个特定的应用来使用不同方法来实现所描述的功能,但是这种实现不应认为超出本发明的范围。Professionals should further realize that the units and algorithm steps described in conjunction with the embodiments disclosed herein can be implemented by electronic hardware, computer software, or a combination of the two. In order to clearly illustrate the relationship between hardware and software Interchangeability. In the above description, the composition and steps of each example have been generally described according to their functions. Whether these functions are executed by hardware or software depends on the specific application and design constraints of the technical solution. Skilled artisans may use different methods to implement the described functions for each specific application, but such implementation should not be regarded as exceeding the scope of the present invention.

结合本文中所公开的实施例描述的方法或算法的步骤可以用硬件、处理器执行的软件模块,或者二者的结合来实施。软件模块可以置于随机存储器(RAM)、内存、只读存储器(ROM)、电可编程ROM、电可擦除可编程ROM、寄存器、硬盘、可移动磁盘、CD-ROM、或技术领域内所公知的任意其它形式的存储介质中。The steps of the methods or algorithms described in connection with the embodiments disclosed herein may be implemented by hardware, software modules executed by a processor, or a combination of both. Software modules can be placed in random access memory (RAM), internal memory, read-only memory (ROM), electrically programmable ROM, electrically erasable programmable ROM, registers, hard disk, removable disk, CD-ROM, or any other Any other known storage medium.

以上仅是本发明的具体实施方式,使本领域技术人员能够理解或实现本发明。对这些实施例的多种修改对本领域的技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所发明的原理和新颖特点相一致的最宽的范围。The above are only specific embodiments of the present invention, so that those skilled in the art can understand or implement the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the invention. Therefore, the present invention will not be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features of the invention herein.

Claims (23)

1.一种心脏起搏器系统,其特征在于,包括体外控制器及体内起搏器,其中,所述体内起搏器内设置有第一鉴权单元,所述体外控制器内设置有第二鉴权单元,所述第一鉴权单元和所述第二鉴权单元通信连接;1. A cardiac pacemaker system, characterized in that it includes an external controller and an internal pacemaker, wherein a first authentication unit is arranged in the internal pacemaker, and a first authentication unit is arranged in the external controller. two authentication units, the first authentication unit and the second authentication unit are connected in communication; 所述体内起搏器,用于获取心脏的心电信息;The internal pacemaker is used to obtain the electrocardiographic information of the heart; 所述体外控制器,与所述体内起搏器通信连接,接收所述体内起搏器发送的所述心电信息,并将接收的控制指令发送给所述体内起搏器。The external controller is communicatively connected with the internal pacemaker, receives the ECG information sent by the internal pacemaker, and sends the received control instruction to the internal pacemaker. 2.根据权利要求1所述的系统,其特征在于,所述系统还包括处理器,其中,所述处理器包括鉴权单元,所述鉴权单元与所述第二鉴权单元通信连接;2. The system according to claim 1, wherein the system further comprises a processor, wherein the processor comprises an authentication unit, and the authentication unit is connected in communication with the second authentication unit; 所述处理器,与所述体外控制器通信连接,接收所述体外控制器发送的所述心电信息,并将控制指令发送给所述体外控制器。The processor is communicatively connected with the external controller, receives the ECG information sent by the external controller, and sends a control instruction to the external controller. 3.根据权利要求2所述的系统,其特征在于,所述处理器为云服务器或智能终端。3. The system according to claim 2, wherein the processor is a cloud server or an intelligent terminal. 4.根据权利要求2所述的系统,其特征在于,所述处理器包括云服务器和智能终端,所述鉴权单元包括第三鉴权单元和第四鉴权单元,所述第三鉴权单元内置于所述云服务器内,所述第四鉴权单元内置于所述智能终端内,所述第三鉴权单元与所述第四鉴权单元通信连接;4. The system according to claim 2, wherein the processor includes a cloud server and an intelligent terminal, and the authentication unit includes a third authentication unit and a fourth authentication unit, and the third authentication unit The unit is built in the cloud server, the fourth authentication unit is built in the smart terminal, and the third authentication unit communicates with the fourth authentication unit; 所述云服务器,与所述体外控制器和所述智能终端通信连接,接收所述体外控制器发送的心电信息,并发送心脏风险信息给所述智能终端;The cloud server communicates with the in vitro controller and the smart terminal, receives ECG information sent by the in vitro controller, and sends heart risk information to the smart terminal; 所述智能终端,与所述体外控制器通信连接,接收所述心脏风险信息,并发送控制指令给所述体外控制器。The intelligent terminal communicates with the external controller, receives the cardiac risk information, and sends control instructions to the external controller. 5.根据权利要求1-4所述的系统,其特征在于,所述体内起搏器包括第一天线,所述体外控制器包括第二天线;5. The system of claims 1-4, wherein the internal pacemaker comprises a first antenna and the external controller comprises a second antenna; 所述体外控制器利用所述第二天线,通过电磁感应耦合的方式向所述第一天线提供电能,所述第一天线用于向所述体内起搏器供电。The external controller uses the second antenna to provide electric energy to the first antenna through electromagnetic induction coupling, and the first antenna is used to supply power to the internal pacemaker. 6.根据权利要求5所述的系统,其特征在于,所述第一天线为镁钙合金制成。6. The system according to claim 5, wherein the first antenna is made of magnesium-calcium alloy. 7.根据权利要求5所述的系统,其特征在于,所述第一天线外设置有可替换的第一生物保护膜,所述第一生物保护膜根据心脏起搏器的使用年限需求进行更换。7. The system according to claim 5, wherein a replaceable first biological protection film is arranged outside the first antenna, and the first biological protection film is replaced according to the service life of the cardiac pacemaker . 8.根据权利要求7所述的系统,其特征在于,所述第一生物保护膜采用聚乳酸乙醇酸、对苯二甲酸乙二醇酯、聚酯纤维或聚醚醚酮制成。8 . The system according to claim 7 , wherein the first biological protection film is made of poly(lactic-co-glycolic acid), ethylene terephthalate, polyester fiber or polyether ether ketone. 9.根据权利要求1-4所述的系统,其特征在于,所述体内起搏器还包括电极,所述电极与心脏内膜或心肌表面连接,通过电流刺激心肌完成起搏。9. The system according to claims 1-4, wherein the internal pacemaker further comprises electrodes, the electrodes are connected to the endocardium or the surface of the myocardium, and stimulate the myocardium to complete pacing through electric current. 10.根据权利要求9所述的系统,其特征在于,所述体内起搏器还包括起搏导线、起搏导线连接器和控制芯片;10. The system according to claim 9, wherein the internal pacemaker further comprises a pacing lead, a pacing lead connector and a control chip; 所述起搏导线与所述电极连接,用于接收所述心电信息;The pacing lead is connected to the electrode for receiving the ECG information; 所述控制芯片通过所述起搏导线与所述起搏导线连接器连接,用于接收所述心电信息。The control chip is connected to the pacing lead connector through the pacing lead for receiving the ECG information. 11.根据权利要求10所述的系统,其特征在于,所述起搏导线外设置有可更换的第二生物保护膜,所述第二生物保护膜根据心脏起搏器的使用年限需求进行更换。11. The system according to claim 10, wherein a replaceable second bioprotective film is arranged outside the pacing lead, and the second bioprotective film is replaced according to the service life of the cardiac pacemaker . 12.根据权利要求11所述的系统,其特征在于,所述第二生物保护膜采用聚乳酸乙醇酸、对苯二甲酸乙二醇酯、聚酯纤维或聚醚醚酮制成。12 . The system according to claim 11 , wherein the second biological protection film is made of poly(lactic-co-glycolic acid), ethylene terephthalate, polyester fiber or polyetheretherketone. 13.根据权利要求10所述的系统,其特征在于,所述起搏导线连接器共4只。13. The system according to claim 10, wherein there are four pacing wire connectors in total. 14.根据权利要求9所述的系统,其特征在于,所述电极为镁钙合金材料或钛合金材料制成。14. The system according to claim 9, wherein the electrodes are made of magnesium-calcium alloy material or titanium alloy material. 15.一种控制心脏起搏的方法,其特征在于,所述方法包括以下步骤:15. A method for controlling cardiac pacing, characterized in that the method comprises the following steps: 体内起搏器获取心脏的心电信息;The internal pacemaker obtains the ECG information of the heart; 体内起搏器和体外控制器之间进行鉴权认证;Authentication between the internal pacemaker and the external controller; 待鉴权认证通过后,体外控制器接收体内起搏器发送的所述心电信息,并将接收的控制指令发送给所述体内起搏器,用以控制心脏起搏。After the authentication is passed, the external controller receives the ECG information sent by the internal pacemaker, and sends the received control instruction to the internal pacemaker to control cardiac pacing. 16.根据权利要求15所述的方法,其特征在于,体内起搏器和体外控制器之间进行鉴权认证过程,包括:16. The method according to claim 15, wherein an authentication process is performed between the internal pacemaker and the external controller, comprising: 所述体内控制器创建设备,并将所述设备的钥匙和密码发送给所述体内起搏器;the in vivo controller creates a device and sends the device's key and password to the in vivo pacemaker; 所述体内起搏器根据接收的钥匙和密码进行预配,并将预配后的登录信息返回给所述体外控制器;The internal pacemaker performs preconfiguration according to the received key and password, and returns the preconfigured login information to the external controller; 所述体外控制器根据返回的所述登录信息进行认证。The in vitro controller performs authentication according to the returned login information. 17.根据权利要求15所述的方法,其特征在于,所述方法还包括:17. The method of claim 15, further comprising: 处理器与体外控制器之间进行鉴权认证;Authentication and authentication between the processor and the in vitro controller; 待鉴权认证通过后,处理器接收所述体外控制器发送的所述心电信息,并将控制指令发送给所述体外控制器。After the authentication is passed, the processor receives the ECG information sent by the external controller, and sends a control instruction to the external controller. 18.根据权利要求17所述的方法,其特征在于,所述处理器为云服务器或智能终端。18. The method according to claim 17, wherein the processor is a cloud server or an intelligent terminal. 19.根据权利要求17或18所述的方法,其特征在于,所述处理器和所述体外控制器之间通过X509证书进行TLS握手,用以进行鉴权认证。19. The method according to claim 17 or 18, wherein the TLS handshake is performed between the processor and the in vitro controller through an X509 certificate for authentication. 20.根据权利要求17所述的方法,其特征在于,所述方法还包括:所述处理器包括云服务器和智能终端,所述处理器与体外控制器间进行鉴权认证,待鉴权认证通过后,处理器接收所述体外控制器发送的所述心电信息,并将控制指令发送给所述体外控制器,包括:20. The method according to claim 17, characterized in that, the method further comprises: the processor includes a cloud server and an intelligent terminal, authentication is performed between the processor and an in vitro controller, pending authentication After passing, the processor receives the ECG information sent by the in vitro controller, and sends control instructions to the in vitro controller, including: 所述云服务器分别与所述体外控制器和所述智能终端进行鉴权认证;The cloud server performs authentication with the in vitro controller and the intelligent terminal respectively; 待鉴权认证均通过后,所述云服务器接收所述体外控制器发送的心电信息,并发送心脏风险信息给所述智能终端;After the authentication and authentication are all passed, the cloud server receives the ECG information sent by the in vitro controller, and sends the heart risk information to the smart terminal; 所述体外控制器与所述智能终端之间进行鉴权认证;performing authentication between the in vitro controller and the intelligent terminal; 待鉴权认证通过后,所述智能终端接收所述心脏风险信息,并发送控制指令给所述体外控制器。After the authentication is passed, the smart terminal receives the heart risk information, and sends a control command to the in vitro controller. 21.根据权利要求20所述的方法,其特征在于,智能终端和云服务器之间进行鉴权认证过程,包括:21. The method according to claim 20, wherein the authentication process between the smart terminal and the cloud server includes: 所述智能终端将账号和密码发送给所述云服务器;The smart terminal sends the account number and password to the cloud server; 若所述账号存在所述云服务器的数据库中,则所述云服务器将所述密码的SHA256值与数据库中的passwd字段值对比是否一致;If the account number exists in the database of the cloud server, whether the cloud server compares the SHA256 value of the password with the passwd field value in the database is consistent; 若一致,则所述云服务器创建一个session对象,并将session_id用setCookie传输给浏览器;If consistent, the cloud server creates a session object, and transmits the session_id to the browser with setCookie; 若浏览器确认setCookie字段存在,则所述智能终端向所述云服务器发送携带Cookies_id的http请求;If the browser confirms that the setCookie field exists, the smart terminal sends an http request carrying Cookies_id to the cloud server; 所述云服务器接收所述http请求并进行确认,确认通过,则获取智能终端信息。The cloud server receives the http request and confirms it. If the confirmation is passed, the smart terminal information is acquired. 22.一种电子设备,其特征在于,包括处理器、通信接口、存储器和通信总线,其中,处理器,通信接口,存储器通过通信总线完成相互间的通信;22. An electronic device, characterized in that it includes a processor, a communication interface, a memory, and a communication bus, wherein the processor, the communication interface, and the memory complete mutual communication through the communication bus; 存储器,用于存放计算机程序;memory for storing computer programs; 处理器,用于执行存储器上所存放的程序时,实现如权利要求15-21任一项所述的方法。When the processor is used to execute the program stored in the memory, it realizes the method according to any one of claims 15-21. 23.一种计算机可读存储介质,其上存储有计算机程序,其特征在于,计算机程序被处理器执行时实现如权利要求15-21任一项所述的方法。23. A computer-readable storage medium, on which a computer program is stored, wherein, when the computer program is executed by a processor, the method according to any one of claims 15-21 is implemented.
CN202211123534.4A 2022-09-15 2022-09-15 Cardiac pacemaker system, cardiac pacing control method and electronic equipment Pending CN115487421A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202211123534.4A CN115487421A (en) 2022-09-15 2022-09-15 Cardiac pacemaker system, cardiac pacing control method and electronic equipment
PCT/CN2023/077208 WO2024055511A1 (en) 2022-09-15 2023-02-20 Cardiac pacemaker system, method for controlling cardiac pacing, and electronic device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211123534.4A CN115487421A (en) 2022-09-15 2022-09-15 Cardiac pacemaker system, cardiac pacing control method and electronic equipment

Publications (1)

Publication Number Publication Date
CN115487421A true CN115487421A (en) 2022-12-20

Family

ID=84467610

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211123534.4A Pending CN115487421A (en) 2022-09-15 2022-09-15 Cardiac pacemaker system, cardiac pacing control method and electronic equipment

Country Status (2)

Country Link
CN (1) CN115487421A (en)
WO (1) WO2024055511A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024055511A1 (en) * 2022-09-15 2024-03-21 首都医科大学附属北京安贞医院 Cardiac pacemaker system, method for controlling cardiac pacing, and electronic device
CN118925067A (en) * 2024-07-26 2024-11-12 华中科技大学同济医学院附属同济医院 A multifunctional pacemaker lead conversion device and its application method

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8838244B2 (en) * 2006-06-02 2014-09-16 Semiconductor Energy Laboratory Co., Ltd. Cardiac pacemaker device with circuits for monitoring residual capacity of battery
CN101352596B (en) * 2008-09-19 2011-06-29 清华大学 In vitro power supply type implantation medical instrument
CN102500057B (en) * 2011-09-28 2014-02-26 上海交通大学 Multifunctional Implantable Gastrointestinal Electrical Stimulation System
EP2760537A4 (en) * 2011-09-30 2015-06-03 Adi Mashiach Device and method for modulating nerves using parallel electric fields
CN104660717B (en) * 2015-03-16 2018-01-23 北京品驰医疗设备有限公司 A kind of method of work of the remote monitoring system of implantable medical devices
CN104683474B (en) * 2015-03-16 2018-01-23 北京品驰医疗设备有限公司 A kind of remote monitoring system of implantable medical devices
CN104689475B (en) * 2015-03-16 2017-09-22 北京品驰医疗设备有限公司 A kind of patient terminal of the remote monitoring system of implantable medical devices
CN104645499A (en) * 2015-03-16 2015-05-27 北京品驰医疗设备有限公司 In vitro controller of implantable medical device for patients
CN106777915B (en) * 2016-11-29 2021-01-05 清华大学 Data processing method and device based on implantable medical system
CN106510688A (en) * 2016-12-21 2017-03-22 北京品驰医疗设备有限公司 Implanted remote monitoring and positioning system
CN108257664B (en) * 2018-01-16 2021-07-06 北京品驰医疗设备有限公司 Communication method and device for implantable medical system
CN111814133A (en) * 2020-05-27 2020-10-23 平安国际智慧城市科技股份有限公司 Mobile application unified login method and device
CN115487421A (en) * 2022-09-15 2022-12-20 首都医科大学附属北京安贞医院 Cardiac pacemaker system, cardiac pacing control method and electronic equipment

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024055511A1 (en) * 2022-09-15 2024-03-21 首都医科大学附属北京安贞医院 Cardiac pacemaker system, method for controlling cardiac pacing, and electronic device
CN118925067A (en) * 2024-07-26 2024-11-12 华中科技大学同济医学院附属同济医院 A multifunctional pacemaker lead conversion device and its application method
US12357832B1 (en) 2024-07-26 2025-07-15 Tongji Hospital, Tongji Medical College, Huazhong University Of Science And Technology Multifunctional pacemaker wire conversion device and application method thereof

Also Published As

Publication number Publication date
WO2024055511A1 (en) 2024-03-21

Similar Documents

Publication Publication Date Title
US10350426B2 (en) Hemodynamically unstable ventricular arrhythmia detection
US10170944B2 (en) Rechargeable impantable cardioverter defibrillator
CN105102060B (en) Systems and methods for leadless pacing and shock therapy
EP2355896B1 (en) Multiple user accounts for managing stored information in an implantable medical device system
CN103189100B (en) Implantable medical device in destructive energy field
US9468772B2 (en) Multi-device implantable medical device system and programming methods
CN110214403A (en) Recharging of Implanted Medical Devices
US20120101544A1 (en) Non-programming activation device for switching modes of an implantable medical device and methods for same
US9937352B2 (en) Rate responsive cardiac pacing control using posture
EP2081643A2 (en) System for neurally-mediated anti-arrhythmic therapy
CN115487421A (en) Cardiac pacemaker system, cardiac pacing control method and electronic equipment
EP1888171B1 (en) Implantable cardioverter defibrillator with programmable capacitor charging level
Peckham et al. Implantable neural stimulators
CN114870258A (en) Implantable cardiac medical device, medical system and medical device control method
JP2011512945A (en) Atrial defibrillation using an implantable defibrillation system
CN219398723U (en) Cardiac pacemaker system
EP4157436B1 (en) Implantable medical device using internal sensors to determine when to switch operational modes
CN106938121A (en) External defibrillation pacing system
US20240307698A1 (en) 5G Implant
JP2025504046A (en) Pulse stimulation control method, device, medical system, electronic device, and medium
CN109125923B (en) A charging pacemaker system for heart conduction is blocked
CN220046845U (en) Heart contractile force regulator capable of removing flutter
US20250256117A1 (en) Defibrillator system
EP4444411B1 (en) Implantable medical devices with pulsed field ablation
US20250222265A1 (en) Patient intervention of antitachyarrhythmia therapy

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination